Loading clinical trials...
Loading clinical trials...
Phase III, National, Multicenter, Randomized, Double-blind Clinical Trial, to Evaluate the Efficacy and Safety of Cipros 20 Association on the Dyslipidemia Treatment
Conditions
Interventions
Cipros 20 association
Crestor 20 mg
Locations
1
Brazil
Allergisa
Campinas, São Paulo, Brazil
Start Date
March 2, 2021
Primary Completion Date
January 23, 2025
Completion Date
January 23, 2025
Last Updated
January 9, 2026
NCT06380322
NCT06568471
NCT05845424
NCT06322056
NCT06578676
NCT06293417
Lead Sponsor
EMS
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions